AstraZeneca Sales, Earnings Rise; Warns of Mounting Legal Challenges in China
In This Article:
The drugmaker posted increased core earnings per share and sales for the first quarter, but also said it could face a fine of up to $8 million in China.
Terms and Privacy Policy